Navigation Links
Solutia Reports First Quarter 2009 Results
Date:5/6/2009

Adjusted Earnings Per Share - Reconciliation of a Non-US GAAP Measure


                                                           Three Months
                                                              Ended
    (in $ millions, except per share data)                March 31, 2009
    --------------------------------------                --------------
    Loss from continuing operations before tax                  $(11)
    Non-GAAP Adjustments (1)                                      (1)
    ------------------------                                      --
    Adjusted earnings from continuing operations before tax      (12)
    Income tax benefit on adjusted earnings                        7
    ---------------------------------------                      ---
    Adjusted earnings for adjusted EPS                           $(5)
    ----------------------------------                           ---


    Diluted Shares (millions)
    -------------------------                                  -----
    Weighted average shares outstanding                        93.27
    Assumed conversion of Restricted Stock                      0.00
    Assumed conversion of Stock Options                         0.00
    -----------------------------------                         ----
    Total Diluted Shares                                       93.27
    --------------------                                       -----
    Adjusted EPS                                               (0.05)
    ------------                                               -----

    (1) See table of Summary of Events Affecting Comparability



                                    SOLUTIA INC.
                        CONSOLIDATED STATEMENT OF OPERATIONS
                  (Dollars in millions, except per share amounts)
                                    (Unaudited)

                                          Successor          Predecessor
          
'/>"/>
SOURCE Solutia Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Solutia to Present at Deutsche Bank Small and Mid Cap Conference
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Hill, SC (PRWEB) October 22, 2014 ... expansion of its cardiovascular pharmacogenetics menu, which enables ... patient outcomes. With PCLS’s evidence-based results, healthcare ... needs and optimize their therapy, while minimizing risks ... In the U.S., according to the FDA [1] ...
(Date:10/22/2014)... 2014 Research and Markets  has announced ... Material, by Application, Geography - Global Analysis and Forecast ... Organic electronics, also called as polymer electronics ... which deals with small conductive molecules and electrically conductive ... and polymers are carbon based, made using synthetic strategies ...
(Date:10/20/2014)... MENLO PARK, Calif. , Oct. 20, 2014 ... announced today that the Company has signed a ... Institute of Regenerative Medicine (CIRM), effective October 1, ... of Clinical Development payments and the release of ... $14.3 million CIRM grant award for clinical development ...
(Date:10/20/2014)... 2014 OncLive® is ... Center at Thomas Jefferson University has joined its ... Strategic Alliance Partnership program, the Sidney Kimmel Cancer ... raise awareness of the Center’s cutting-edge research programs, ... Clinicians and other health care professionals from the ...
Breaking Biology Technology:PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3
... Calif., March 31 Watson Pharmaceuticals, Inc. (NYSE: ... today that the United States District Court for the ... of Concerta (methylphenidate hydrochloride extended-release tablets) does not infringe ... that the ,373 Patent is invalid. The opinion, ...
... One of the nation,s leading independent research institutes ... align to support the critical mission of protecting the ... solutions. , , Officials at ... expanding MRI,s existing operations by establishing a wholly owned ...
... process platform intended to meet the needs of the Obama ... ... Aliso Viejo, California (PRWEB) March 29, 2009 -- Applied Technology ... BodySensor™ and BodyBalance™ system from its new Digital Data ...
Cached Biology Technology:Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid 2Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors 2Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors 3Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors 4Company to Provide Technology Platform for Digital Data Collection of Computerized Patient Records 2
(Date:10/15/2014)... is spreading rapidly and to an unexpected extent. The ... past and the virus shows a new disease dynamic ... For this reason, the German National Academy of Sciences ... Engineering, and the Union of the German Academies of ... Ebola epidemic today. , In the statement the academies ...
(Date:10/15/2014)... 15, 2014   Neurotechnology , a provider ... availability of the VeriLook Surveillance 3.0 software ... real-time biometric face identification using live video streams ... The new version not only identifies faces in ... objects while they are moving through the video ...
(Date:10/14/2014)... fly genome for the first time, revealing robust immune ... thrives in pathogen-rich dung piles and garbage heaps. , ... Genome Biology , will increase understanding of house fly ... to resist insecticides, which could lead to novel control ... transmit more than 100 human and animal diseases, including ...
Breaking Biology News(10 mins):Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3House fly genome reveals expanded immune system 2
... Jan. 13, 2011 Genomic research could help doctors ... patients, according to a study by Genomic Health Inc. (Nasdaq: ... drug, oxaliplatin, is widely used in colon cancer. It is ... are likely to recur. It is also used in advanced ...
... and Hyde relationship with mercury, but researchers at the ... a discovery that ultimately could help explain the split ... aquatic environments make methylmercury, a more toxic form of ... nature and other types of bacteria can transform methylmercury ...
... Middle schools soon might add fast cafeteria lines to ... according to Penn State researchers. The U.S. Department of ... to Amit Sharma, assistant professor; Martha Conklin, associate professor, ... health sciences, College of Medicine. The project will use ...
Cached Biology News:TGen and Genomic Health Inc. discover genes affecting cancer drug 2Natural dissolved organic matter plays dual role in cycling of mercury 2Quick school cafeteria lines could lead to healthier food choices 2
EDTA, tetrasodium salt, 1 kg. Ethylene diaminetetraacetic acid.Dihydrate. Assay: 99-101% (as is).Risks: 36, 37, 38 ; Safety Precautions: 22, 36, 37. Category: Nucleotides & Enzymes & Biochemicals, Ul...
...
Request Info...
...
Biology Products: